Platelet membrane fluidity individuals at risk for Alzheimer's disease: A comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy

Psychopharmacology

Volumn 145, Issue 2, 1999, Pages 175-180

  Zubenko, George S ^a,b,c   Kopp, Ursula ^a   Seto, Tomoyoshi ^a   Firestone, Leonard L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Biophysical properties; Fluorescence and ESR spectroscopy; Platelet membrane

Indexed keywords

STEARIC ACID DERIVATIVE;

ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; CELL TRANSFORMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; FEMALE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MALE; MEMBRANE FLUIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK FACTOR; THROMBOCYTE MEMBRANE;

ADULT; AGED; ALZHEIMER DISEASE; ANISOTROPY; BLOOD PLATELETS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; HUMANS; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; RISK; SPECTROMETRY, FLUORESCENCE;

EID: 0032804188     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051046     Document Type: Article

References (47)

1. Bacchus H (1976) Essentials of Metabolic Diseases and Endocrinology. University Park Press, Baltimore, pp 81-120
2. Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P (1990) The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 26:15977-15983
3. Chakravarti A, Slaugenhaupt S, Zubenko GS (1989) Inheritance pattern of platelet membrane fluidity in Alzheimer's disease. Am J Hum Genet 44:799-805
4. Cohen BM, Zubenko GS, Babb S (1987) Abnormal platelet membrane composition in Alzheimer's disease. Life Sci 40: 2445-2451
5. Cole GM, Galasko D, Shapiro IP, Saitoh T (1990) Stimulated platelets release amyloid beta-protein precursor. Biochem Biophys Res Commun 170:288-295
6. Corash L, Tan H, Gralnick HR (1977) Heterogeneity of human whole blood platelet subpopulations: I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 49:71-87
7. Di Luca M, Pastorino L, Cattabeni F, Zanardi R, Scarone S, Racagni G, Smeraldi E, Perez J (1996) Abnormal pattern of platelet APP isoforms in Alzheimer's disease and Down syndrome. Arch Neurol 53:1162-1166
8. Eagger S, Hajimohammadreza I, Fletcher K, Levy R, Brammer M (1990) Platelet membrane fluidity, family history, and severity and age of onset in Alzheimer's disease. Int J Geriatr Psychiatry 5:395-400
9. Folstein MF, Folstein SE, HcHugh PR (1975) "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
10. Gaffney BJ, McNamee CM (1974) Spin label measurements in membranes. Biomembranes Methods Enzymol 32:161-198
11. Haass C (1996) Presenile because of presenilin. The presenilin genes and early onset Alzheimer's disease. Curr Opinion Neurol 9:254-259
12. Hajimohammadreza I, Brammer MJ, Eagger S, Burns A, Levy R (1990) Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochim Biophys Acta 1025:208-214
13. Haltia M, Viitanen M, Sulkava R, Ala-Hurula V, Poyhonen M, Goldfarb L, Brown P, Levy E, Houlden H, Crook R et al. (1994) Chromosome 14-encoded Alzheimer's disease: Genetic and clinicopathological description. Ann Neurol 36:362-367
14. Heyn MP (1979) Determination of lipid order parameters and rotational correlation times from fluorescence depolarization experiments. FEBS Lett 108:359-364
15. Hicks N, Brammer MJ, Hymas N, Levy R (1987) Platelet membrane properties in Alzheimer and multi-infarct dementias. Alzheimer Dis Assoc Disor 1:90-97
16. Hubbell WL, McConnell HM (1971) Molecular motion in spin-labeled phospholipids and membranes. J Am Chem Soc 93:314-326
17. Hunt WA (1985) Alcohol and Biological Membranes. Guilford Press, New York, pp 14-40
18. Jähnig F (1979) Structural order of lipids and proteins in membranes: Evaluation of fluorescence anisotrophy data. Biophysics 76:6361-6365
19. Jarrett JT, Berger EP, Lansbury PT (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697
20. Kálmán J, Dey I, Ilona SV, Matkovics B, Brown D, Janka Z, Farkas T, Joó F (1994) Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia. Biol Psychiatry 35:190-194
21. Piletz JE, Sarasua M, Whitehouse P, Chotani M (1991b) Intracellular membranes are more fluid in platelets of Alzheimer's disease patients. Neurobiol Aging 12:401-406
22. Pottell H, Van der Meer BW, Hereman W (1983) Correlation between the order parameter and the steady-state fluorescence anisotropy of 1,6-dipheny1-1,3,5 hexatrine and an evaluation of membrane fluidity. Biochim Biophys Acta 730:181-186
23. Prendergast FG, Haughland RP, Callahan PJ (1981) 1-[4(Trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene. Synthesis, fluorescence properties, and use as a flourescence probe of lipid bilayers. Biochemistry 20:7338-7345
24. Querfurth HW, Selkoe DJ (1994) Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33:4450-4561
25. Schlossmacher MG, Ostaszewski BL, Hecker LI, Celi A, Haass C, Chin D, Lieberburg I, Furie BC, Furie B, Selkoe DJ (1992) Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging 13:421-434
26. Seelig J (1970) Spin label studies of oriented smectic liquid crystals (a model system for bilayer membranes). J Am Chem Soc 92:3881-3887
27. Selkoe DJ (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298
28. Shinitzky M, Barenholz Y (1978) Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 515:367-394
29. Sweet RA, Zubenko GS (1994) Peripheral markers in Alzheimer's disease. In: Burns A, Levey R (eds). Chapman and Hall. London, pp 387-403
30. Van Blitterswijk WJ, van Hoevn RP, Van der Meer BW (1981) Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta 644:323-332
31. van Rensburg SJ, Carstens ME, Potocnik FCV, Aucamp AK, Taljaard JF, Koch KR (1992) Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminum on platelet and erythrocyte membranes. Neurochem Res 17:825-829
32. Zubenko GS (1986) Hippocampal membrane alteration in Alzheimer's disease. Brain Res 385:115-121
33. Zubenko GS (1989) Endoplasmic reticulum abnormality in Alzheimer's disease: Selective alteration in platelet NADH-cytochrome C reductase activity. J Geriatr Psychiatr Neurol 2:3-10
34. Zubenko GS (1992) Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology 6:77-93
35. Zubenko GS (1997) Molecular neurobiology of Alzheimer's disease (syndrome?). Harvard Rev Psychiatry 5:1-37
36. Zubenko GS, Cohen BM (1985a) Effects of phenothiazine treatment on the biophysical properties of platelet membranes from psychiatric patients. Biol Psychiatry 20:384-396
37. Zubenko GS, Cohen BM (1985b) Effects of psychotropic agents on the physical properties of platelet membranes in vitro. Psychopharmacology 85:369-373
38. Zubenko GS, Cohen BM (1986) A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines. Psychopharmacology 88:230-236
39. Zubenko GS, Ferrell RE (1988) Monozygotic twins concordant for probable Alzheimer's disease and abnormal platelet membrane fluidity. Am J Med Genet 29:431-436
40. Zubenko GS, Malinakova I (1987) Temperature dependence of the molecular dynamics of platelet membranes in Alzheimer's disease. Biol Psychiatry 22:987-994
41. Zubenko GS, Cohen BM, Boller F, Malinakova I, Keefe N, Chojnacki B (1987a) Platelet membrane abnormality in Alzheimer's disease. Ann Neurol 22:237-244
42. Zubenko GS, Cohen BM, Reynolds CF, Boller F, Malinakova I, Keefe N (1987b) Platelet membrane fluidity in Alzheimer's disease and major depression. Am J Psychiatry 144:860-868
43. Zubenko GS, Malinakova I, Chojnacki B (1987c) Proliferation of internal membranes in platelets from patients with Alzheimer's disease. J Neuropathol Exp Neurol 46:407-418
44. Zubenko GS, Wusylko M, Boller F, Cohen BM, Teply I (1987d) Family study of platelet membrane fluidity in Alzheimer's disease. Science 238:539-542
45. Zubenko GS, Huff FJ, Beyer J, Auerbach J, Teply I (1988) Familial risk of dementia associated with a biological subtype of Alzheimer's disease. Arch Gen Psychiatry 45:889-893
46. Zubenko GS, Teply I, Winwood E, Huff FJ, Moossy J, Sunderland T, Martinez AJ (1996) Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: Results at five years. Am J Psychiatry 153:420-423
47. Zubenko GS, Winwood E, Jacobs B, Teply I, Stiffler JS, Hughes HB, Huff FJ, Sunderland T, Martinez AJ (1999) Pospective study of risk factors for Alzheimer's disease: Results at 7.5years. Am J Psychiatry 156:50-57